Rebus Holdings, Inc. (RBSH)

Market Cap	385.60K
Revenue (ttm)	n/a
Net Income (ttm)	-942,000
Shares Out	32.13M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,102
Open	0.0080
Previous Close	0.0117
Day's Range	0.0080 - 0.0120
52-Week Range	0.0050 - 0.0278
Beta	-11.29
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About RBSH

Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RBSH